Dr. Stuart A. Lipton, MD, PhD

Dr. Lipton practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Lipton's NPI, 1578596292, was assigned on July 8, 2006. Dr. Lipton graduated from Perelman School of Medicine - Philadelphia in 1977. Dr. Lipton holds California license G85439.

Dr. Lipton's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Lipton's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Lipton is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health. Dmand AI also links Dr. Lipton to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lipton practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lipton's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lipton is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lipton's licenses on file in 3 states: California, Maine and Massachusetts.

Dmand AI lists epilepsy, fibromyalgia and chronic pain, neuropathy, non-alzheimer's dementia (chronic), parkinson's disease, sleep apnea and thoracic spine disorders among the conditions Dr. Lipton treats.

CMS data shows 40 Medicare services from Dr. Lipton across 1 procedure code in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $5,281 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Dr. Lipton in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lipton's median patient age at 78, with 54% women.

In 2024, Dr. Lipton wrote 246 Medicare Part D claims for 24 patients. 95% of them were for generic drugs. CMS names the drug for 193 of them, across 11 drugs with 11 or more claims each, at $8,003 in total drug cost. In 2023, CMS named 189 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Lipton for performance year 2024, reported as part of a group. Dr. Lipton accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lipton as offering telehealth.

Dmand AI links 248 papers to Dr. Lipton, published from 2002 to 2025. 2016 was the busiest year, with 8. The most frequent topics are Neurons, Cells, Cultured and Nitric Oxide. Dr. Lipton has published most often in Proc Natl Acad Sci U S A. Dr. Lipton's most frequent co-authors are Eliezer Masliah, MD, Gary Tong, MD, PhD and James Milton Parker, MD.

Dmand AI links Dr. Lipton to 1 clinical trial. Conditions studied include Anemia, Sickle Cell and Anemia, Hemolytic, Congenital. Open Payments lists research payments to Dr. Lipton that name 1 trial.

CMS Open Payments shows 36 general payments to Dr. Lipton from 9 drug and device companies from 2016 to 2023. Travel and lodging make up the largest share, 40% of the total. Eli Lilly and Company paid the most, $9,640. It also lists 2 research payments totaling $15,400 from 2016 to 2022, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Lipton, most recently CMS Stage 1 EHR in 2013.

Dr. Lipton graduated from Perelman School of Medicine - Philadelphia in 1977.

Dr. Lipton is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.